Crossmark

Tumor and immune remodeling following radiotherapy in human renal cell carcinoma

Crossref DOI link: https://doi.org/10.1136/jitc-2022-006392

Published Online: 2023-04-20

Published Print: 2023-04

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Chow, Jacky https://orcid.org/0000-0002-3849-0346
Khan, Adil https://orcid.org/0000-0002-0717-3268
Gaudieri, Madeline

Wasik, Brianna J

Conway, Alexis

Soh, Kah Teong

Repasky, Elizabeth A

Schwaab, Thomas

Wallace, Paul K

Abrams, Scott I https://orcid.org/0000-0002-8742-4708
Singh, Anurag K https://orcid.org/0000-0002-6703-5115
Muhitch, Jason B https://orcid.org/0000-0002-7703-1425
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01892930 at ClinicalTrials.gov

Documents that mention this clinical trial

Tumor and immune remodeling following radiotherapy in human renal cell carcinoma
https://doi.org/10.1136/jitc-2022-006392
Funding

Funding for this research was provided by:

National Center for Advancing Translational Sciences (UL1TR001412)

U.S. Department of Defense (W81XWH2010720)

National Cancer Institute (P30CA016056)
License Information

License valid from 2023-04-19